Advertisement
News
Advertisement

Hansen Medical to Exhibit Magellan Robotic System at 8th Annual European Symposium of Vascular Biomaterials in France

Mon, 05/06/2013 - 8:03am
The Associated Press

Hansen Medical, Inc., a global leader in intravascular robotics, today announced that it will be exhibiting its Magellan™ Robotic System at the 8th Annual European Symposium of Vascular Biomaterials (ESVB) from Friday, May 10th to Monday, May 13th at the Strasbourg Hilton in Strasbourg, France. The Company's Magellan Robotic System is installed at Hôpital Civil Strasbourg and has been utilized in numerous successful cases since that time. The Company will be exhibiting the Magellan Robotic System at Booth 5.

Additionally, Francis Macnamara, Hansen Medical's Vice President of Advanced Technology, will be delivering a presentation at the conference titled, "Basics about the Remote Endovascular Catheter Navigation Magellan System" at 8:15 AM on Saturday, May 11th.

"We are excited to be exhibiting our technology at the ESVB Conference, which provides an interactive platform for key opinion leaders and vascular specialists to collaborate and discuss advancements in endovascular technologies," said Bruce Barclay, President and CEO of Hansen Medical. "We have a large and growing pipeline of clinical interest in our Magellan System, and we continue to build on this momentum through exhibitions at conferences such as ESVB and the recent Charing Cross Symposium."

About the Magellan™ Robotic System
Hansen Medical's Magellan Robotic System is based upon the flexible robotic technology incorporated in the Sensei-X® Robotic Catheter System currently sold in the U.S. and Europe, which has been used in over 10,000 patients, but includes a number of key enhancements. In particular, the Magellan Robotic System:

Provides solid catheter stability for placement of therapeutic devices. Is designed to enable predictable procedure times and increased case throughput. Allows for independent, individual robotic control of the distal tips of both the outer sheath and the inner leader catheter, as well as robotic manipulation of standard guidewires. Is designed to allow for sufficient extension inside the body to access hard to reach peripheral anatomy. Preserves the open architecture featured in the Sensei System to allow for the subsequent use of many 6F therapeutic devices on the market today. Is designed to potentially reduce physician radiation exposure and fatigue by employing a remote physician workstation.

About Hansen Medical, Inc.
Hansen Medical, Inc., based in Mountain View, California, is the global leader in intravascular robotics, developing products and technology designed to enable the accurate positioning, manipulation and control of catheters and catheter-based technologies. The Company's Magellan™ Robotic System, NorthStar™ Robotic Catheter and related accessories, which are intended to facilitate navigation to anatomical targets in the peripheral vasculature and subsequently provide a conduit for manual placement of therapeutic devices, have undergone both CE marking and 510(k) clearance and are commercially available in the European Union, and the U.S. In the European Union, the Company's Sensei® X Robotic Catheter System and Artisan Control Catheter are cleared for use during electrophysiology (EP) procedures, such as guiding catheters in the treatment of atrial fibrillation (AF), and the Lynx® Robotic Ablation Catheter is cleared for the treatment of AF. This robotic catheter system is compatible with fluoroscopy, ultrasound, 3D surface map and patient electrocardiogram data. In the U.S. the Company's Sensei X Robotic Catheter System and Artisan Control Catheter were cleared by the U.S. Food and Drug Administration for manipulation and control of certain mapping catheters in EP procedures. In the United States, the Sensei System is not approved for use in guiding ablation procedures; this use remains experimental. The U.S. product labeling therefore provides that the safety and effectiveness of the Sensei X System and Artisan Control Catheter for use with cardiac ablation catheters in the treatment of cardiac arrhythmias, including AF, have not been established. Additional information can be found at www.hansenmedical.com.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading